Stocksigma LogoStocksigma Logo

Augmont Enterprises Reports IPO Proceeds Utilization for Q2 FY27 Monitoring Period

CARE Ratings confirmed zero material deviation in Augmont Enterprises' utilization of its ₹620.00 crore fresh IPO proceeds for the quarter ended 30th

Augmont Enterprises Reports IPO Proceeds Utilization for Q2 FY27 Monitoring Period

Augmont Enterprises Ltd · Others (Uncategorized) · 06 Nov 2026, 5:18 pm

Augmont Enterprises Reports IPO Proceeds Utilization for Q2 FY27 Monitoring Period CARE Ratings confirmed zero material deviation in Augmont Enterprises' utilization of its ₹620.00 crore fresh IPO proceeds for the quarter ended 30th Sep'26. The company deployed ₹573.40 crore during the period, comprising ₹465.23 crore for working capital requirements (gold and silver procurement), ₹107.76 crore for general corporate purposes, and ₹0.41 crore toward offer expenses. The unutilized balance of ₹46.60 crore is maintained in HDFC Bank's public offer account, with remaining issue-related expenses slated for settlement by end-Dec'26.

Original exchange filing (PDF)

More announcements from Augmont Enterprises Ltd

All Augmont Enterprises Ltd announcements